What is reps and warranties insurance in M&A?
Reps and warranties insurance is a third-party insurance policy that backstops the indemnification obligations of the seller in an M&A transaction, allowing the seller to keep more sale proceeds at close rather than holding them in escrow.
Quick answer
Reps and warranties insurance (RWI) is a buyer-side policy that covers financial losses from breaches of seller representations in the purchase agreement, typically priced at 2.5 to 4 percent of coverage amount for healthcare deals.
The detail
RWI has become standard in middle-market healthcare M&A above $30 million enterprise value. Without RWI, the buyer typically requires the seller to leave 10 to 15 percent of the purchase price in escrow for 18 to 24 months to cover any post-close indemnification claims. With RWI, the escrow drops to 0.5 to 1 percent (a retention), and the insurance policy takes the rest of the risk. The cost: 2.5 to 4 percent of the coverage amount as a one-time premium, usually split between buyer and seller or fully paid by one side depending on market conditions. Healthcare deals see higher premiums because of regulatory risk (Stark, Anti-Kickback, HIPAA), billing compliance, and clinical matters. Underwriting takes 2 to 3 weeks and requires a comprehensive diligence package. Exclusions almost always include known issues, wage and hour matters, and some tax positions, which still need to be covered through traditional escrow or indemnity.
RWI premiums in healthcare M&A typically run 2.5 to 4 percent of coverage amount, higher than the 2 to 3 percent for most industries due to regulatory exposure.
Source: ABA Business Law Section
RWI is now used in a majority of middle-market ($50M to $500M) healthcare transactions, per AICPA M&A practice data.
Source: AICPA M&A Practice Guidance
What this means for clinic owners
From Sorso
If the deal size supports it, push hard for RWI. Moving even 8 percent of the purchase price out of escrow and into your bank account at close, rather than 18 months later, is one of the most underrated levers in practice sale negotiations.
Related questions
How do PE firms value medical practices?
Private equity firms value medical practices primarily on a multiple of trailing twelve-month adjusted EBITDA, typically 5x to 12x, with the multiple driven by scale, growth, payer mix, and provider retention.
What is a quality of earnings report?
A quality of earnings (QoE) report is a buyer-commissioned financial due diligence analysis that normalizes EBITDA, tests the reliability of revenue and expenses, and identifies risks that affect purchase price, typically costing $50K to $150K for a healthcare practice.
What is an LOI in healthcare M&A?
A letter of intent (LOI) in healthcare M&A is a non-binding agreement that sets the proposed purchase price, structure, exclusivity period, and diligence timeline before a buyer commits the resources to close a deal.
How long does it take to sell a medical practice?
Selling a medical practice to a PE buyer typically takes 6 to 12 months from engagement to close, with 2 to 3 months of prep, 1 to 2 months of marketing, 2 to 3 months of diligence and negotiation, and 1 to 2 months for definitive documents and closing.
Founder of Sorso. 19 years in corporate finance. Managed a $450M loan portfolio before building a fractional CFO firm exclusively for healthcare clinics.
Want to see how your practice measures up?
Take the 4-minute financial assessment. It is free, and it will show you where your practice is leaking money.